Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting [Letter]

Currie, Craig John, McEwan, Phil, Poole, Chris, Valentine, William J., Palmer, Andrew J., Lammert, Morten, Nicklasson, Lars, Foos, Volker and Roze, Stéphane 2006. Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting [Letter]. Current Medical Research and Opinion 22 (5) , pp. 967-969. 10.1185/030079906X00000

Full text not available from this repository.

Official URL: http://dx.doi.org/10.1185/030079906X00000

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Informa Healthcare
ISSN:	0300-7995
Last Modified:	04 Jun 2017 06:37
URI:	https://orca.cardiff.ac.uk/id/eprint/62867

Actions (repository staff only)

Edit Item

Dimensions

Altmetric

CORE (COnnecting REpositories)